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Summary.-Peritoneal macrophages from Sarcoma-180-bearing mice against
Staphylococcus aureus were studied to determine the in vitro phagocytic capacities.
When the phagocytic system was opsonized with normal mouse serum, macrophage
phagocytic activity increased markedly soon after tumour graft and then returned
to normal. A new antiphagocytic factor was detected in the serum of tumour-bearers
soon after tumour implantation. This factor was of tumour origin, stable even at a
temperature of56°C for 30 min and non-dialysable. Peptone-starch-induced macro-
phages were less sensitive to the factor than their unstimulated counterpart.
CONFLICTING observations have been
reported on the state of macrophage
phagocytic function in tumour-bearers.
The carbon-clearance ability of the
reticuloendothelial system, the non-
specific phagocytic function performed
mainly by liver macrophages, is severely
repressed soon after Lewis lung carcinoma
transplantation in mice (Otu et al., 1977).
It was reported by Gudewicz & Saba
(1977) that alveolar macrophages from
Walker 256 carcinosarcoma-bearing rats
showed considerably depressed phago-
cytic activity against Pseudomonas
aeruginosa. There is other evidence, how-
ever, that neoplastic disease induces a
stimulation of macrophage phagocytic
function. For instance, Meltzer & Steven-
son (1978) reported that phagocytosis of
IgG-coated sheep erythrocytes by macro-
phages was significantly augmented in
tumour-bearing mice.
The present study was undertaken to
determine whether or not the alteration
of phagocytic capacity can be detected in
macrophages from Sarcoma-180-bearing
animals, using viableStaphylococcus aureus
as the phagocytic material. We also
attempted to examine whether or not
changes in capacity ofmacrophage phago-
cytosis are caused by a factor of tumour
origin.
We found that phagocytosis of bacteria
by macrophages from tumour-bearers was
remarkably enhanced in the early phase
after tumour implantation. We also found
a suppressive factor against macrophage
phagocytic function with a mol. wt
> 10,000 in the mouse serum soon after
tumour graft.
MATERIALS AND METHODS
Mice.-Colony-bred DD mice of both
sexes were purchased from Shizuoka Union
for Experimental Animals, Shizuoka, Japan.
Tumour.-Sarcoma-180 (S-180) an allo-
transplantable tumour kindly provided by
Dr I. Umezawa (Kitasato Institute, Tokyo)
was maintained by serial s.c. passage in DDY
mice. The tumour was excised under aseptic
conditions and finely minced in phosphate-
buffered saline (PBS, pH 7.2) containing 100
jug/ml of streptomycin. The resulting cell
suspension was filtered through an 80-mesh
stainless-steel screen and wa,shed once with
PBS. Usually each animal was given 106
tumour cells s.c. into the right flank.
Bacterium.-S. aureus Strain 209P was
obtained from Dr Y. Kanemasa (Okayama
University, Medical School, Okayama., Japan)
and maintained in heart-infusion agar. TheH. SAITO AND H. TOMIOKA
organism was inoculated into brain/heart
infusion broth (Difco Lab., U.S.A.) and cul-
tured at 37T for 18-24 h. The cells were
centrifuged at 2000 9 for 15 min, washed once
with PBS and finally suspended in Hanks'
balanced salt solution (pH 7 4) containing
0-01% crystalline bovine serum albumin
(Sigma Co., U.S.A.) and 0-0056M glucose
(referred to as HBG).
Serum.-Serum was obtained from the
normal or tumour-bearing mice by ex-
sanguination from the heart and stored at
-800C.
Peritoneal and peritoneal-exudate cells.-
Peritoneal-exudate cells (PEC) were obtained
from mice given 5% proteose peptone-5%
soluble starch i.p. 3 days before harvest by
the following method. A 6ml portion of HBG
containing 5 i.u./ml of heparin (Novo Co.,
Denmark) was injected into the abdominal
cavity of each mouse. The mice were ex-
sanguinated and 5 ml of the peritoneal fluid
from each mouse was withdrawn. Samples of
the peritoneal fluid from 5-15 mice were
pooled, centrifuged at 200 g for 10 min at
4°C, treated with distilled water for 30 sec
to lyse the erythrocytes, and then washed
with HBG. Viability of the resultant cell
preparation was estimated by the nigrosin-
exclusion test to be 90-98%. Peritoneal
cells (PC) were collected from untreated
mice in the same way as mentioned
above, and the viability was estimated at
92-98%. The cell population of PC and PEC
was analysed by microscopy after Giemsa
staining. PC were composed of62-75% mono-
nuclear phagocytes, 5-14% granulocytes, and
19-32% lymphocytes, whilst PEC consisted
of 60-77% mononuclear phagocytes, 10-24%
granulocytes, and 8-20% lymphocytes.
Phagocytosis test.-Phagocytosis was meas-
ured by two methods designated as "colony-
forming unit (CFU) assay" and "microscopic
assay".
CFU assay was carried out according to the
method of Cohn & Morse (1959). The phago-
cytosing mixture (0 5 ml) in siliconized sterile
tubes (10 x 100 mm) contained 1-4-38 X106
PC or PEC, 105 bacteria, sample serum, and
HBG. The tubes were sealed with rubber
stoppers and then incubated at 37°C on a
reciprocal shaker at 160-180 cycles/min. At
intervals of up to 240 min, phagocytosis was
stopped by the addition of 5 ml of cold PBS
containing 0.05% bovine serum albumin,
followed by centrifugation at 200 g for 4 min.
In a preliminary test, no significant reduction
in the recovery of extracellular bacteria was
noted after this centrifugation procedure.
From the upper one third of the tube, 0.5 ml
ofthe supernatant was withdrawn and count-
ed for its CFU on nutrient agar plates.
For the microscopic assay, phagocytosis
was performed in the same manner as
described above except for the incubation
mixture: 1 2 x 106 PC or PEC, 8 x 105 bac-
teria, sample serum, and HBG. After phago-
cytosis, the cell pellet obtained by centrifuga-
tion at 200 g for 4 min was smeared, fixed with
methanol, and stained with Giemsa solution.
By light microscopy, the number of macro-
phage-ingested bacteria was counted, and the
percentage of the phagocytosing cells to total
macrophages was calculated (% phago-
cytosing cells). In some cases, the mean
number of ingested bacteria per phagocyte
was also recorded.
S-180 tumour-cell culture.-S-180 tumour-
cell suspension prepared by the method men-
tioned above ("Tumour") was given i.p. at a
dose of 106 cells/mouse. Eight to 10 days
later the ascitic cells were collected, treated
with distilled water, and washed with Eagle's
minimal essential medium (MEM). The re-
sultant cells (6 x 107) were suspended in
30 ml of MEM containing 10% foetal bovine
serum (Microbiological Associates Inc.,
U.S.A.) in a 500ml glass culture bottle and
incubated at 37°C for 1 h. Non-adherent cells
were collected and the same procedure was
repeated. The final cell suspension was com-
posed mainly of tumour cells ( >90%) while
the remainder was mononuclear phagocytes
and lymphocytes. Tumour cells were then
cultured in MEM supplemented with 10%
foetal bovine serum at 37°C for up to 3 days
in 5% CO2 and 95% humidified air.
Calculation.-The value of the "relative
opsonization index", which means the rela-
tive opsonic activity of the sample serum as
compared with normal mouse serum (NMS),
was calculated as follows:
Relative opsonization index (%)
CFU (-serum) - CFU
(+sample serum)
x 100
CFU(-serum)-CFU (+NMS)
or
%phag (+sample serum) -
%M %phag (-serum) x 100
- phag ( +NMS)-%phag (-serum)
260ANTIPHAGOCYTIC FACTOR OF TUMOUR ORIGIN
where CFU means extracellular CFU after
phagocytosis and %phag indicates percent-
age of phagocytosing cells.
RESULTS
Alteration in the phagocytic function of
macrophages after tumour implantation
Changes in phagocytic capacity of the
peritoneal macrophages from tumour-
bearers against S. aureus were studied
after s.c. injection of S-180 tumour cells
into 8-week-old male mice (8 mice per
regimen). At intervals after tumour graft,
PC and serum were drawn from the same
mice of each experimental group, pooled,
and examined for phagocytic and opsonic
activities, respectively. The results are
summarized in Fig. l. When phagocytosis
was performed without addition of serum,
the phagocytic ability of macrophages
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FIG. 1.-Changes in macrophage phagocytic
function after S-180 tumour implantation
in mice. (A) Peritoneal resident macro-
phages were obtained from tumour-bearing
mice at the indicated time and examined
for phagocytic capacities against S. aureus
in the absence (A) or presence of either
10% NMS (0) or 10% S-180 MS (0)
sampled at the same time. (B) Yields of
total peritoneal cells (PC El) and mono-
nuclear phagocytes (*) per g body wt,
and tumour wt (A) at the indicated time.
from tumour-bearers was not altered
significantly for up to 20days aftertumour
implantation. In contrast, phagocytosis in
the presence of NMS markedly increased
on the 1st day, persisted through the 5th
day, and returned to almost normal levels
by the 20th day (the increases 1-5 days
after tumour graft were statistically sig-
nificant, P< 0-005 by x2 test). On the other
hand, phagocytosis in the presence of
serum from tumour bearers (S-180 MS)
remarkably increased on the 1st day
(P< 0'005 by x2 test), rapidly decreased
by the 3rd day, remained low for 2 addi-
tional days, and then gradually returned
to the 1st-day level.
These findings indicate that the phago-
cytic activity of macrophages against
S. aureus is enhanced, particularly in the
latent period of the tumour growth. It is
also suggested that the opsonic activity of
S-180 MS is reduced 3-5 days after tumour
transplantation.
Decrease in opsonic activity of S-180 MS
after tumour graft
To ascertain the net changes in opson-
izing ability of S-180 MS after tumour
injection, the value of the "relative
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FIG. 2.-Opsonic activity of S-180 MS as a
function of time after tumour implanta-
tion. The values of "relative opsonizing
index" were calculated from the data in
Fig. 1, using the equation in the text. (0)
10% S-180 MS vs 10% NMS; (0) 10%
S-180 MS+10% NMS vs 20% NMS; (A)
tumour wt.
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opsoiiizatioil inidex" was calculated from
the data in Fig. 1. As shown in Fig. 2,
tumour implantation quickly resulted in a
depressed opsonic activity of S-180 MS,
the lowest level being reached on the 3rd
day after tumour graft (open circles). It
was also observed that the value with
mixed serum (10% each of S-180 MS and
NMS) changed similarly to the case of
8-180 MS alone (solid circles).
Antiphagocytic factor in S-180 MS
The results shown in Fig. 2 suggest the
presence of an antiphagocytic substance,
since decreased opsonic activity of S-180
MS was not fully overcome by supple-
mental addition of NMS as the opsonin
source. We therefore attempted to deter-
mine whether a similar phenomenon
could be also observed using macrophages
from normal mice by microscopic assay.
As shown in Fig. 3, the phagocytic ability
of peptone-starch-elicited macrophages
from normal mice (open bar) was mark-
edly suppressed when S-180 MS was added
instead of NMS. This suppression was not
overcome even when S-180 MS was
Addition (v/v) Macrophage
None _ ,_ M
10% NMS
10% S-180 MS
20% NMS
10% NMS
+ 10% S-180 MS
0 1 2 3 4
No. of ingested bacteria / phagocyte
Fie'x. 3.-Effect of S-180 MIS on bacterial
pliagocytosis of peptone-starcll-incluced
macrophages andl PMN from normal mice.
Phagocytosis assay was carrie(d out by
microscopy on the basis of the number of
bacteria ingested per phagocyte. Eaclh ex-
periment was performed in duplicate and
the means an(l variations are in(licated. In
this assay system, the 990% confidence
limit (Student's t test) was calculated as
+ 5-47%.
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FIG. 4. Effect of S-180 MIS on bacterial
phagocytosis of peptone-starclb-induced
macrophages from normal mice. Macro-
pbage pbagocytosis of S. aureus was per-
formed in the absence (*) and presence
of 10% NAIS (0), 10% S-180 A1IS (A) or
10% S-180 MS plus NAIS (A). Tlhe assay
was carrie(1 out by the CFU metho(l. In the
absence ofmacrophages (i3Z), bacterial CFU
didl inot change significantly during the
incubation time.
The bar in(licates the 950 con-
fit(ence limit (Student's t test).
supplemented with a sufficient amount of
serum opsonins, by further addition of
NMS. On the contrary, as shown also in
Fig. 3, bacterial phagocytosis of poly-
morphonuclear leucocytes (PMN; shaded
bar) was not reduced as significantly as in
the case of macrophages, when S-180 MS
was added instead of NMS. It is note-
worthy that stimulation of PMN phago-
cytosis by the addition of NMS as the
opsonin source was not as marked as in
the case of macrophages. These observa-
tions indicate that S-180 MS contains an
antiphagocytic factor or factors specific-
ally effective on macrophages, but not on
PMN.
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As illustrated in Fig. 4, the phagocytic
ability of PEC from normal mice given
peptone-starch 3 days before harvest
(measured by CFU assay) was also
markedly reduced when S-180 MS was
added instead of NMS (open triangles vs
open circles). In this case, PEC were com-
posed of 70%/ macrophages, 14% PMN,
and 16% lymphocytes. Therefore, using
the data presented in Fig. 3, it may be
estimated that about 8.3% of the total
bacterial phagocytosis of the PEC in the
presence of 10% NMS is due to con-
taminating PMN. Similarly, when 10%
S-180 MS was added instead of NMS, the
contaminating PMN can be regarded as
the cause of about 16% of the total
phagocytosis. However, since the present
antiphagocytic factor specifically acts on
macrophages but not on PMN as indicated
in Fig. 3, the reduction of bacterial
phagocytosis observed here can be regard-
ed as mainly due to the depression of
the phagocytic capacity of macrophages,
but not of PMN. Furthermore, there was
no reversal of the reduction of macro-
phage phagocytosis when S-180 MS was
supplemented with a further addition of
NMS as the opsonin source (solid tri-
angles). This indirectly suggests that the
reduced macrophage phagocytic capacity
in the presence of S-180 MS is not cor-
rected by supplemental addition of NMS,
because the bacterial phagocytic activity
ofPMN did not differsignificantly between
the cases where S-180 MS was added alone
or with supplemental NMS, as shown in
Fig. 3. These observations indicate again
that S-180 MS has a suppressive factor
against macrophage phagocytic function.
It was also noted that S-180 MS ex-
hibited a dose-dependent suppression of
the bacterial phagocytosis ofmacrophages
(data not shown).
Stimulated macrophages have a reduced
sensitivity to the antiphagocyticfactor
As can be seen in the first column of
Table I (Experiment 1) percentage re-
ductions in "relative opsonization index"
(which means the sensitivity of macro-
phages to the action of the present anti-
phagocytic factor) were 63 + 20 and 29 +
400 for resident and peptone-starch-
stimulated macrophages, respectively. In
this case, bacterial phagocytosis tests
were performed on PC and PEC from nor-
mal mice by the CFU assay. The PC and
PEC used here were found to be composed
of 70 and 65% mononuclear phagocytes,
and to be contaminated with 7*3 and 10%
PMN respectively. Therefore it seems that
bacterial phagocytosis due to contamin-
ating PMN dose not exceed 10% of total
phagocytosis in both cases, at most, since
PMN phagocytic capacity was found to be
less than (or equal to) that of macro-
phages in the presence of various serum
TABLE I.-Comparison of resident and peptone-starch-induced macrophages as related
to sensitivity to the antiphagocyticfactor ofS-180 MS
% Reduc-
tion of
Macrophage opsonic Relative
Exp. Macrophage donor Serum addition activitya sensitivityb Assay
1 Resident Normal mice 10% S-180MS* 63 + 20 CFU
Peptonet Normalmice 10% 8-18OMS 29+4 46
2 Resident S-180 mice: 10% S-18OMS 98 + 3 Microscopy
Peptone S-180 mice 10% S-180MS 71+ 2 72
3 Resident S-180 mice 10% S-18OMS + 10% NMS 58 + 13 Microscopy
Peptone S-180 mice 10% S-180MS + 10% NMS 34 + 17 59
a % Reduction of opsonic activity= 100-"relative opsonization index (%o)" of sample serum. The mean
and variation of two observations are presented.
b Relative sensitivity of each kind of macrophage to the antiphagocytic factor, taking the values of
resident macrophages as 100.
* S-180 MS was obtained 3 days after tumour implantation.
t Peptone-starch-induced macrophage.
I S-180 tumour-bearing mice, 3 days after tumour graft.
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supplements as shown in Fig. 3. Moreover,
as can be seen in Fig. 3, the present anti-
phagocytic factor in S-180 MS exhibits
none of the significant suppressive actions
against PMN phagocytic function. Thus
the reductions in opsonic activity ob-
served here for PC and PEC can be re-
garded as representing mainly depression
of macrophage phagocytic ability by the
antiphagocytic factor, but not of PMN
phagocytosis. Similar results were ob-
tained in separate experiments by micro-
scopic assay using PC and PEC from
S-180tumour-bearing mice (Exps 2 and 3).
These findings suggest that macrophages
stimulated with peptone-starch are more
resistant to the inhibitory action of the
antiphagocytic factor than their un-
stimulated counterparts. It may be worth
noting that sensitivity of macrophages
from S-180-tumour-bearing animals to the
antiphagocytic factor is considerably
greater than that of macrophages from
normal donors (Exps 1 & 2). However, in
a separate experiment, it was found by
microscopic assay that the 00 reduction
of opsonic activity of peptone--starch-
induced macrophages from normal mice
was 55 + 120%. This value is not much
lower than the value, 71 + 2%, obtained
for peptone-starch-elicited macrophages
from S-180 tumour-bearing mice. Thus it
seems most likelv that the difference
between both types of macrophages from
TABLE IT.-Effect ofphysical treatments on
antiphagocytic activity ofS-180 MS
Extracellular
CFU per tube
Serum addition ( x 103)a
20% NMS 1-70 + 0-23
10% NMS + 10% S-180 AIS 2-98 + 0 33
10% NMS + 10% dialysed S-180 MS* 2-88 + 0-26
10% NMS + 10% heated NMSt 1-73 + 0-69
10% NMS + 10% heated S-180 MSt 3 40 + 0 40
a Number of viable extracellular staphylococci
per tube after 2h phagocytosing incubation. The
mean values of 4 observations of experimental data
+ s.e. (Student's t test) are indicated.
* S-180 MS obtained 3 days after tumour graft
was dialysed against 100 vol of PBS overnight.
t 56°C for 30 min.
S-180 tumour bearers and normal mice in
their sensitivities to the antiphagocytic
factor simply reflects the different assay
systems used, rather than a real effect.
The results are given in Table II. When
10% ofS-180 MS was added to the phago-
cytozing incubation mixture (using pep-
tone-starch-induced PEC from normal
mice as phagocytes) with a supplementary
addition of an equal amount of NMS, the
extracellular CFU after 2h phagocytosis
was nearly twice that of the control (20%
NMS added) indicating the antiphago-
cytic action of S-180 MS. A similar degree
of antiphagocytic activity was also noted
when 10% S-180 MS which had been
thoroughly dialysed against PBS, in place
of untreated S-180 MS, was added to the
phagocytosis system. Thus, it appears that
the antiphagocytic factor does not pass
through the dialysis membrane. It was
also found that addition of 10% ofheated
S-180 MS (560C for 30 min) produced a
remarkable reduction in phagocytosis,
whereas only a slight decrease was ob-
tained when 100% ofNMS similarly treated
was added. This indicates that the anti-
phagocytic factor is stable to heat treat-
ment at 56°C for 30 min. This factor could
be precipitated at 50% saturation of
ammonium sulphate.
Origin of the antiphagocyticfactor
In attempts to determine the origin of
this antiphagocytic factor, we investigated
whether or not a similar factor is produced
by S-180 tumour cells in vitro. Three-day
cultured fluid of S-180 tumour cells was
dialysed against PBS and fractionated
with 50%-saturated ammonium sulphate.
The precipitate was redissolved in PBS,
dialysed against the same buffer, and then
made up to 1/15 volume ofstarting culture
fluid. This was sterilized for 5 min by UV-
irradiation using a 15W UV lamp at
20 cm.
As indicated in Fig. 5, phagocytic
ability of peptone-starch-induced macro-
phages from normal mice linearly de-
creased as the amount offraction obtained
from S-180 cell culture fluid increased.
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FIG. 5.-Dose response of antiphagocytic
activity of tlie fraction obtaine(d by
ammonium sulphate precipitation at 50%
saturation from 3-(lay-old S-180 ttimour-
cell culture fluid. Each plot and its bar
indicate the mean of 4 observ-ations and the
95%o confidence limit, (Studlent's t test),
respectively.
Thus, the antiphagocytic factor is appar-
ently produced in the culture fluid of
S-180 tumour cells. It should be noted that
the fraction exhibited antiphagocytic
activity even after UV irradiation, indi-
cating that the antiphagocytic action of
S-180 cell culture fluid is not virally
mediated. Moreover, this is supported by
the observation that both S-180 MS and
culture fluid of S-180 cells heated at
1 00°C for 5 min showed the same level of
antiphagocytic activity as that of un-
treated preparations. Spleen cells from
normal mice were also found to produce
an antiphagocytic substance, but the
amount was considerably lower than that
from S-180 cells (data not shown).
DISCUSSION
The objective of the present work was
to determine whether or not alteration of
the phagocytic capacity of macrophages
from 8-180 tumour-bearing mice can be
detected in the in vitro bacterial phago-
cytosis system. The following conclusions
were drawn.
The s.c. implantation of the tumour in
mice induced a marked increase in macro-
phage phagocytosis of S. aureus in the
presence of NMS, as an opsonin source.
This was noted particularly in the latent
period of tumour growth. A similar result
was obtained when the mean number of
bacteria ingested per macrophage was
estimated instead of '" ofphagocytosing
cells" (data not shown). (In these cases
phagocytosis was performed under sub-
optimal conditions.) Accordingly, it seems
that this early increase in bacterial phago-
cytosis of macrophages from tumour-
bearing mice is due to both the increase in
the cell population of highly phagocytic
macrophages and a certain enhancement
in phagocytic capacity of individual
phagocytes. A similar observation has been
described concerning macrophage phago-
cytosis of IgG-coated sheep erythrocytes
in cases of Fibrosarcoma 1038 and Hepa-
toma 129 (Meltzer & Stevenson, 1978).
The serum from tumour-bearing mice
showed a remarkable reduction in opson-
izing activity soon after tumour graft.
This situation can be mainly attributed to
the presence of some antiphagocytic factor
of tumour origin in S-180 MS, since the
supplementary addition of NMS (as an
opsonin source) into the phagocytic system
failed to reverse the depression of opsonic
activity in S-180 MS. However, it is not
clear whether this antiphagocytic factor
merely acts as a competitive inhibitor
against serum opsonins or actually alters
the macrophage phagocytic function.
The present antiphagocytic factor was
stable to heat treatment at 56°C for 30
min and non-dialysable through dialysis
nmembrane. Thus, it probably has a mol.
wt > 10,000. In addition, it was observed
that cultured S-180 tumour cells actually
produced a similar antiphagocytic factor.
Accordingly, the antiphagocytic factor
detected in S-180 MS is considered to
originate from S-180 tumour cells per se.
The present antiphagocytic factor of
S-180 tumour origin seems to differ from
I I I I1 ---
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the humoral factor of Hepatoma 129
origin which has an inhibitory activity on
macrophage chemotaxis (Pike & Snyder-
man, 1976) or the factor ofSAI spindle-cell
sarcoma origin with a suppressive activity
against macrophage bactericidal function
(North et al., 1976a). Both these factors
are dialysable and their mol. wts are con-
sidered to be <10,000. It is noteworthy
that the antiphagocytic factor of S-180
tumour origin showed no significant in-
hibitory action against macrophage
staphylocidal activity (data not shown).
The depressed state ofopsonizing ability
of S-180 MS 3-5 days after tumour graft
was subsequently restored, and replaced
by a contrasting state, somewhat more
active than NMS. As indicated by North
et al. (1976b, 1977) it seems likely that this
phenomenon coincided with the expression
of T-cell-mediated concomitant immunity
to tumour in the recipient mice, i.e. the
appearance of T-cell-derived stimulating
factor(s) of macrophage phagocytosis in
the serum of S-180 tumour-bearers after
the latent period of tumour growth.
As indicated in Table I, peptone-starch-
induced macrophages were more resistant
to the antiphagocytic action ofthe present
S-180 tumour factor than the resident
macrophages. This suggests that stimula-
tion of macrophages with certain agents
can overcome the subversion of the
phagocytic function by the tumour factor.
Our results may assist in elucidating the
conflicting data of Meltzer & Stevenson
(1978) and Otu et al. (1977) concerning the
macrophage phagocytic function in
tumour-bearers. The former found in in
vitro studies that macrophage phago-
cytosis of IgG-coated erythrocytes was
markedly increased in cases of Fibro-
sarcoma 1038- and Hepatoma 129-bearing
mice. It was also reported that the tumour
serum failed to suppress the macrophage
phagocytic function when the serum was
given to normal recipients. On the con-
trary, Otu et al. (1977) reported that host
carbon clearance ability, a nonspecific
phagocytic activity of mainly liver macro-
phages, was considerably reduced early
after Lewis lung carcinoma implantation
in mice. They also found that the serum
from tumour-bearers caused a significant
decrease in carbon clearance ability of the
recipient mice. In 5-180 tumour-bearing
mice, the phagocytic capacity of macro-
phages from tumour-bearers was enhanced
significantly in the latent period oftumour
growth, when the in vitro phagocytosis was
performed in the presence of a sufficient
amount of NMS as the opsonin source. In
addition, a large amount of antiphago-
cytic factor was produced in the serum of
tumour-bearing mice also in the latent
period of tumour growth. These observa-
tions strongly suggest that the stimulation
of macrophage phagocytic function soon
after tumour graft actually occurs in all
the cases, whereas the amount of anti-
phagocytic factor of tumour origin differs
considerably between types oftumours. In
the cases of Fibrosarcoma 1038 and
Hepatoma 129 (Meltzer & Stevenson,
1978) the failure of the tumour sera to
depress the macrophage phagocytic ability
of the recipient animals indicates a small
amount of antiphagocytic factor. In con-
trast, it appears that a large amount of
antiphagocytic factor is produced in the
serum of Lewis lung carcinoma-bearing
mice as this tumour serum given to normal
mice caused a marked reduction in the
carbon-clearance ability of liver macro-
phages of the recipients (Otu et al., 1977).
Therefore the apparent reduction in the
carbon-clearance ability of Lewis lung
carcinoma-bearers seems to be due to the
antiphagocytic effect of the serum factor
of tumour origin rather than to a decrease
in the macrophage phagocytic function
per se.
In any case, the apparent alteration in
macrophage phagocytic capacity after
tumour transplantation probably depends
on the amount (activity) ofantiphagocytic
factor in the serum of tumour-bearing
animals. However, there remains the
possibility that the contradictory situa-
tions mentioned above are merely due to
the different phagocytic particles used in
the above studies.
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Purification ofthe antiphagocytic factor
of S-180 tumour origin is now under way,
and results will be reported elsewhere.
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